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Abstract: The Amaryllidaceae family is well known for its pharmacologically active 
alkaloids. An important approach to treat Alzheimer’s disease involves the inhibition of the 
enzyme acetylcholinesterase (AChE). Galanthamine, an Amaryllidaceae alkaloid, is an 
effective, selective, reversible, and competitive AChE inhibitor. This work was aimed at 
studying the alkaloid composition of four wild Argentinian Amarillydaceae species for the 
first time, as well as analyzing their inhibitory activity on acetylcholinesterase. Alkaloid 
content was characterized by means of GC-MS analysis. Chloroform basic extracts from 
Habranthus jamesonii, Phycella herbertiana, Rhodophiala mendocina and Zephyranthes 
filifolia collected in the Argentinian Andean region all contained galanthamine, and 
showed a strong AChE inhibitory activity (IC50 between 1.2 and 2 µg/mL). To our 
knowledge, no previous reports on alkaloid profiles and AChEIs activity of wild 
Argentinian Amarillydaceae species have been publisihed. The demand for renewable 
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sources of industrial products like galanthamine and the need to protect plant biodiversity 
creates an opportunity for Argentinian farmers to produce such crops. 
Keywords: Argentinian Amaryllidaceae wild; alkaloids; galanthamine; lycorine; tazettine; 
acetylcholinesterase inhibitors 
 
1. Introduction 
Many species of medicinal and aromatic plants are cultivated for such industrial uses, but most are 
still collected in the wild. The demand for renewable sources of industrial products and the need to 
protect plant biodiversity create an opportunity for farmers to produce such plants as crops. More than 
25% of the pharmaceutical drugs used in the World today are derived from plant natural products [1]. 
In the conventional pharmaceutical industry, pharmaceutical companies produce drugs from 
compounds extracted from plant material, or use plant derived compounds as starting material to 
produce drugs semi-synthetically [2]. Examples of the former include the anti-cancer alkaloid 
paclitaxel from Pacific yew (Taxus brevifolia), vinblastine from the Madagascar periwinkle 
(Cataranthus roseus), and digoxin from the foxglove (Digitalis lanata) [1]. 
The alkaloids of the Amaryllidaceae family are extensively studied for their biological activities in 
several pharmaceutical areas, for example, Alzheimer’s disease (AD), a neurodegenerative problem of 
enormous economic and social impact (15 million people, mainly in developed countries, suffer from 
the symptoms of this disease). The treatment is based on drugs that increase levels of acetylcholine. 
Galanthamine is a long-acting, selective, reversible and competitive inhibitor of acetylcholinesterase 
(AChE) and an allosteric modulator of the neuronal nicotinic receptor for acetylcholine. AChE is 
responsible for the degradation of acetylcholine at the neuromuscular junction, in peripheral and 
central cholinergic synapses. Galanthamine has the ability to cross the blood-brain barrier and to act 
within the central nervous system [3,4]. According to data presented by the Alzheimer’s Association in 
2007, the prevalence of Alzheimer’s disease will quadruple by 2050. Galanthamine hydrobromide has 
superior pharmacological profiles and higher tolerance as compared to the original AChE inhibitors, 
physostigmine or tacrine [5]. This alkaloid galanthamine (biosynthesized exclusively by species of 
Amaryllidaceae family) is the treatment for mild and moderate stages of the AD. Galanthamine, 
approved in 2001 by FDA (Razadyne®), was originally isolated from Galanthus woronowii. While 
several total syntheses of the alkaloid galanthamine are available [6–10], current marketing is done 
mainly by the limited extraction of natural populations of Leucojum aestivum from Turkey (of varying 
quality and low content of active principle), or from small plantations of this species in Bulgaria, 
which are insufficient to meet current pharmaceutical company demand. The worldwide production of 
galanthamine is about 250 kg per year. Around 61 species of the Amaryllidaceae family grow in 
Argentina, covering a wide variety of genera (Chlidanthus, Crinum, Habranthus, Haylockia, 
Hieronymiella, Hippeastrum, Phycella, Rhodophiala, Stenomesson and Zephyranthes) [11]. To our 
knowledge, there are no reports on the chemistry and biological activity of Argentinian species 
belonging to the Amaryllidaceae group. 
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Our search for plant raw materials for medicinal products is now aimed at investigating the 
acetylcholinesterase inhibitory activity (AChE) of basic chloroform extracts (BCE) obtained from 
Habranthus jamesonii, Phycella herbertiana, Rhodophiala mendocina, and Zephyranthes filifolia 
(Amaryllidaceae species that grow in Argentine) to find new sources of production of galanthamine, 
and other potential alkaloids for treating AD. AChE inhibitory activity was determined by the 
spectrophotometric method by Ellman et al. [12]. Alkaloid profiles were analyzed by gas 
chromatography-mass spectrometry (GC–MS). 
2. Results and Discussion  
The AChE inhibitory activity of the BCE from Habranthus jamesonii, Phycella herbertiana, 
Rodophiala mendocina and Zephyranthes filifolia species, collected from the Andean region of San 
Juan (SJ), Mendoza (MDZ), and Neuquén (NQN) provinces (Argentine), were tested according to the 
methodology developed by Ellman et al. [12] with some modifications [13]. Galanthamine was used as 
a positive control. The results, expressed as IC50 values (µg/mL) are shown in Table 1. BCE showed 
the highest acetylcholinesterase inhibitory activity, with IC50 values ranging from 1 to 2 µg/mL 
(reference compound: galanthamine 0.29 ± 0.07 µg/mL). The BCE-Z. filifolia MZA and BCE-H. 
jamesonii SJ displayed the highest inhibition towards AChE with similar values (IC50 1 ± 0.01  
and 1 ± 0.08 µg/mL respectively) only three times higher than that of galanthamine. BCE-P. 
herbertiana SJ was found to have the second highest inhibition on AChE (IC50 values 1.2 ± 0.12 µg/mL). 
Acetylcholinesterase inhibition was similar to that of specie R. mendocina regardless of collection site 
(IC50 values 2 ± 0.15, 2 ± 0.20 µg/mL). BCE-H. jamesonii SJ showed a similar AChE inhibitory 
activity (IC50 values 2 ± 0.11 µg/mL). The yield percentages of the basic chloroform extract (BCE) 
(g/100 g dry bulbs) are reported in Table 1. BCE-Zephyranthes filifolia SJ had the lowest percentage at 
0.21%, whereas BCE-Rhodophiala mendocina SJ gave the highest one at 0.38%. 
Table 1. Acetylcholinesterase Enzyme Inhibition of Wild Argentinian Amaryllidaceae 
extracts expressed as IC50 [μg/mL]. 
Samples (voucher number) 
BCE a 
Yield [%] b IC50 [μg/mL] 
Phycella herbertiana SJ (IBT-Arg1) 0.34 1.2 ± 0.12 
Habranthus jamesonii SJ (IBT-Arg2) 0.25 2.0 ± 0.11 
Rhodophiala mendocina SJ (IBT-Arg3) 0.38 2.0 ± 0.15 
Zephyranthes filifolia SJ (IBT-Arg4 ) 0.21 1.0 ± 0.08 
Habranthus jamesonii MZA (IBT-Arg5) 0.27 1.0 ± 0.01 
Rhodophiala mendocina NQN (IBT-Arg6) 0.26 2.0 ± 0.20 
Galanthamine c  0.29 ± 0.07 
a Basic chloroform extract, b Percentage yield BCE [w/w], c Reference compound. 
The alkaloids detected by GC-MS in the BCE-H. jamesonii MZA, BCE-H. jamesonii SJ, BCE-P. 
herbertiana SJ, BCE-R. mendocina NQN, BCE-R. mendocina SJ and BCE-Z. filifolia SJ are listed in 
Table 2. 
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Table 2. Alkaloid composition of four Amaryllidaceae plants. 
Compound 
H. jamesonii a P. herbertiana a R. mendocina a Z. filifolia a 
SJ MZA SJ SJ NQN SJ 
Trisphaeridine (1) 0.7   0.1  1.2 
Ismine (2)      0.7 
5,6-Dihydrobicolorine (3)      1.7 
Galanthamine (4) 1.4 4.3 4.2 0.6 0.8 17.8 
Lycoramine (5) 1.9  27.4 3.2   
Lycoraminone (6)   0.5    
Vittatine (7) 13.2  0.1 1.2 0.2  
Narwedine (8)  0.8 0.2  0.4 0.9 
Anhydrolycorine (9) 2.5 1.5 0.4 0.9   
A-289 (10) 1.1      
A-315 (11)   0.4    
A-249 (12) 1.3 0.8     
A-319 (13) 1.1      
Montanine (14) 5.7  1.8 9.1   
Haemanthamine/Crinamine(15) b 2.9  2.5 31.2 6.8  
Tazettine (16) 28.1  5.4 32.9  69.7 
A-301 (17) 2.0      
Pancracine (18)    0.3   
11-Hydroxyvittatine (19) 18.7 3.1 4.6    
Galanthine (20) 4.9  17.2    
Lycorine (21) 8.2 43.6 33.2 13.3 20.4  
Incartine (22)   1.1    
Methylpseudolycorine (23)   0.2    
Epimacronine (24)    0.6   
8-O-Demethylhomolycorine (25)   0.6    
Homolycorine type (26)    3.9   
2-O-Acetyllycorine (27)   0.2 2.6   
A-345 (28)  2.7     
Tazettamide (29)  3.5     
m/z 109 (Homolycorine type) (30)  7.7     
Sanguinine (31)  0.5     
m/z 83 (285) (32)  1.1     
m/z 297(33)  11.8     
m/z 281 (34)  0.9     
m/z 283 (35)  2.3     
N-Demethylgalanthamine (36)     0.2  
2-O-Methylpancracine (37)     3.8  
N-Formylnorgalanthamine (38)     0.1  
Total Alkaloids identified 40.0 84.6 99.1 99.9 32.7 92.0 
a Values are expressed as GC-MS area %, b Cannot be distinguished by GC-MS. 
Galanthamine (4) was found in all the species and it ranged from 0.6 to 17.8% of total ion current 
(TIC). Zephyranthes filifolia presented the highest galanthamine (4) content (17.8% TIC, Figure 1, 
whereas R. mendocina showed the lowest one (0.6% TIC). The highest AChE inhibitory activity of 
these species (IC50 1.0 ± 0.08 µg/mL) belonged to BCE-Z. filifolia SJ a fact that could be related to the 
high content of galanthamine (4). 
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Figure 1. Representative GC-MS Chromatogram of Wild Argentinian Amaryllidaceae 
BCE-Z. filifolia SJ. Peaks: 1: Trisphaeridine; 2: Ismine; 3: 5,6-Dihydrobicolorine;  
4: Galanthamine 8: Narwedine; 16: Tazettine. 
 
Galanthamine (4) content was collection site dependent: the BCE-H. jamesonii SJ sample presented 
1.4% galanthamine TIC, while the BCE-H. jamesonii MZA with 4.3% TIC was four times higher. The 
differences in alkaloid content, depending on geographical distribution of H. jamesonii populations, 
coincides with a previous report on the European species. Berkov et al. [14], reported an intraspecies 
diversity in alkaloid profiles in Galanthus elwesii and G. nivalis populations collected in different 
locations in Bulgaria. They presented galanthamine TIC between 0 and 46%. The main alkaloid types 
(chemotypes) showed a wide variation in the number of compounds comprising their alkaloid mixture. 
Genetic and environmental factors and their interaction play a role in determining alkaloid profiles. 
Additionally, sanguinine (31), identified in BCE-H. jamesonii MZA (0.5% TIC), has a hydroxyl 
group at C9 instead of a methoxyl group, and is around 10 times more active than galanthamine (4). 
Although the differential content could indicate that some environmental parameters might be 
influencing galanthamine (4) production, this specie could be considered for the sustainable production 
of galanthamine. A similar galanthamine (4) content (4.2% TIC) has been found in BCE-P. 
herbertiana SJ. BCE-R. mendocina SJ and BCE-R. mendocina NQN, showed a similar galanthamine 
content (<1% TIC). Narwedine (8), another AChE inhibitor [15] was found in all the populations 
studied (with the exception of the H. jamesonii and R. mendocina collected in San Juan province), but 
this compound comprised no more than 1% TIC. Other main alkaloids characterized by GC-MS in the 
BCE-P. herbertiana SJ were lycorine (21) (33%), lycoramine (5) (27%) and tazettine (16) (5.4%). 
The occurrence of trisphaeridine (1), galanthamine (4), lycoramine (5), vittatine (7), anhydrolycorine 
(9), montanine (14), haemanthamine/crinamine (15), tazettine (16), 11-hydroxyvittatine (19), galanthine 
(20), lycorine (21) and tazettamide (29) are reported for the first time in Habranthus jamesonii from 
Argentina. According to the literature, haemanthamine (15) and galanthine (20), have been reported 
previously in Habranthus brachyandrus, a specie of the genus [16]. At the same time, thirteen 
alkaloids were characterized in BCE-R. mendocina SJ, whereas five of them montanine (14), vittatine 
(7), haemanthamine (15), tazettine (16) and lycorine (21) have been previously reported as constituents 
16  
8 
4
3 
1 2
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of Rhodophiala bifida [17]. The main alkaloids identified in native Amaryllidaceae species from San 
Juan, Mendoza and Neuquén (Argentina) are shown in Figure 2. 
Figure 2. Main alkaloids in Wild Amaryllidaceae Species from Argentina. 
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The presence of main alkaloids identified by GCMS (lycorine (21) and tazettine (16) as percentage 
of the total ion current (TIC) is consistent with that observed in TLC alkaloid profiles of chloroform 
basic extract (Figure 3). 
Figure 3. TLC Analysis of Argentinian Amaryllidaceae (BCE). 1: H. jamesonii,  
2: P. herbertiana, 3: R. mendocina, 4: Z. filifolia, 5: Galanthamine, 6: Lycorine, 7: Tazettine. 
The AChE inhibitory activity of these species can be explained by the presence of other AChE 
inhibitors in the alkaloid mixtures. Montanine (4) has shown significant AChE inhibitory activity [18], 
1 2 3 4 5 6 7 
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while a weak activity has been reported for lycorine (21) and haemanthamine (15) [19]. The other 
major alkaloids, lycoramine (5) and tazettine (16) have no AChE inhibitory activity [13] while, to the 
best of our knowledge, no AChE inhibitory activity assays have been performed for galanthine (20), 
11-hydroxyvittatine, 2-O-acetyllycorine (27).  
The alkaloids found in the Argentinian species studied possess other interesting biological 
properties besides their AChE inhibitory activity. Haemanthamine (15) is a potent inducer of 
apoptosis [20], and has antimalarial activity [3]. Vittatine (7) has shown cytotoxic activity [3]. 
Antibacterial activity has been reported for vittatine (7) and 11-hydroxyvittatine (19) [21]. Lycorine 
(21) exhibits citotoxic, apoptotic, antiviral, antifungal, anti-protozoan [22], and anti-inflammatory 
activities [23]. It is a good candidate for a therapeutic agent against leukemia [24].Analgesic and 
hypotensive effects have been reported for galanthine (20) [3]. Moderate cytotoxic activity has been 
reported for tazettine (16) [25] which is an isolation artefact of chemically labile pretazettine. This 
compound, which is indeed present in plants, has shown remarkable cytotoxicity against a number of 
tumor cell lines [3]. In addition to the alkaloids identified in the species studied, other unknown 
compounds (10, 11, 12, 13, 17, 26, 28, 30, 32, 33, 34, and 35) were detected in minor quantities, 
showing mass spectral patterns that also suggest structures related to the Amaryllidaceae alkaloids. 
Isolation studies are currently being developed. 
3. Experimental 
3.1. Plant Material 
Wild plants of the species Habranthus jamesonii (BAK) Rav, Phycella herbertiana LINDL, 
Rhodophiala mendocina (PHIL.) Rav., and Zephyranthes filifolia (HERB.) ex Kraenzlin 
(Amaryllidaceae) were collected in the Andean regions of San Juan (SJ), Mendoza (MZA), and 
Neuquén (NQN) provinces (Argentina), during the flowering period between October and March 
2009-2010 and then transferred to flowerpots and kept under greenhouse conditions. The species 
collected and identified, and voucher numbers are shown in Table 1. Figure 4 shows a map of the 
collection area. All plant species were authenticated by MCS German Roitman when they were 
collected. Voucher specimens were deposited at the Instituto de Biotecnología (UNSJ) with the codes: 
IBT-UNSJ- Arg1-6. 
3.2. Alkaloid Extraction 
Dried bulbs (100 g per each plant) were extracted under reflux three times with MeOH (300 mL) 
for 1 h each. The solvent was evaporated under reduced pressure to give the methanolic crude extracts 
(MCEs). MCEs were dissolved in H2SO4 (2% v/v) and neutral material was removed with CHCl3  
(200 mL). Then, the aqueous solutions were basified with 25% NaOH up to pH 10–12 and the 
alkaloids were extracted with CHCl3 (3  500 mL) to obtain the basic chloroform extract (BCE). After 
evaporation of the organic solvent, the dry alkaloid fractions were dissolved in MeOH for GC/MS 
analysis. The BCE were named as BCE-H. jamesonii MZA, BCE-H. jamesonii SJ, BCE-P. 
herbertiana SJ, BCE-R. mendocina NQN, BCE-R. mendocina SJ and BCE-Z. filifolia SJ after  
their origin. 
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Figure 4. Collection areas of Argentinian wild Amaryllidaceae. 
 
3.3. Gas Chromatography-Mass Spectroscopy Analyses 
GC-MS analyses were performed on a Hewlett Packard 6890/MSD 5975 instrument  
(Hewlett Packard, Palo Alto, CA, USA) operating in EI mode at 70 eV. A DB-5 MS column  
(30 m  0.25 mm  0.25 μm) was used. The temperature program was: 100–180 °C at 15 °C min−1,  
1 min hold at 180 °C, 180–300 °C at 5 °C min−1, and 1 min hold at 300 °C. Injector temperature was 
280 °C. The flow rate of carrier gas (He) was 0.8 mL min−1. The split ratio was 1:20. The results 
obtained were analyzed using AMDIS 2.64 software (NIST). Compounds were identified through the 
comparison of their mass spectral patterns and retention indexes, with the data recorded in literature. 
3.4. Microplate Assay for Acetylcholinesterase Activity 
AChE activity was assayed as described by Ellman et al. [12] with some modifications [13]. Fifty 
μL of AChE in buffer phosphate (8 mM K2HPO4, 2.3 mM NaH2PO4, 0.15 M NaCl, 0.05% Tween 20, 
pH 7.6) and 50 μL of the sample dissolved in the same buffer were added to the wells. The plates were 
incubated for 30 minutes at room temperature before the addition of 100 μL of the substrate solution 
(0.1 M Na2HPO4, 0.5 M DTNB, 0.6 mM ATCI in Millipore water, pH 7.5). The absorbance was read 
in a Labsystems microplate reader (Helsinki, Finland) at 405 nm after three minutes. Enzyme activity 
was calculated as a percentage compared to an assay using a buffer without any inhibitor. The AChE 
inhibitory data were analyzed with the software package Prism (Graph Pad Inc., San Diego, CA, 
USA). IC50 values are means ± SD of three individual determinations each performed in triplicate. 
  Phycella herbertiana 
  Zephyranthes filifolia  
  Habranthus jamesonii  
  Rhodophiala mendocina  
San Juan 
Mendoza 
Neuquén 
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3.5. TLC Analysis of BCE 
TLC was carried out on Merck Silica gel 60 F254 plates, using chloroform-methanol-ammonia 
(99:9:1) mixtures as mobile phase. TLC plates were sprayed with Dragendorff’s reagent; main 
alkaloids gave orange spots. 
4. Conclusions 
The findings of the present study demonstrate the potential of wild Argentinian Amaryllidaceae 
species collected in the central Andean region, as a new renewable source of galanthamine. The most 
promising species seen to be H. jamesonii MDZ and Z. filifolia SJ. The demand for renewable sources 
of galanthamine and the need to protect plant biodiversity create an opportunity for Argentinian 
farmers to produce such crops. Studies of domestication of some of these species are currently in 
progress in order to determine which crops can be cultivated outdoors in the particular climate and 
soil, and which can be grown in greenhouses. Production cost and galanthamine levels in traditional 
cultivars are also being analyzed. 
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